HyperQ is a suite of algorithms implemented in software that provides in-depth and unique clinical value for the diagnosis and monitoring of ischemic heart disease. It can be applied on various monitoring or diagnostic platforms, including standard ECG devices and wearables. HyperQ offers a non-invasive and highly reliable solution for the diagnosis and monitoring of Ischemic Heart Disease and Acute Coronary Syndrome. The technology analyzes the high-frequency QRS depolarization segment of the cardiac cycle, providing superior clinical accuracy compared to other non-invasive solutions. HyperQ is FDA cleared and CE marked, and it can be installed on the cloud or integrated into an ECG system. BSP Medical aims to provide early detection of cardiac disease through analysis of ECG stress or rest tests, offering an innovative platform for advanced ECG analysis.